W P KOLB
Overview
Explore the profile of W P KOLB including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1031
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bradt B, KOLB W, Cooper N
J Exp Med
. 1998 Aug;
188(3):431-8.
PMID: 9687521
Large numbers of neuritic plaques (NP), largely composed of a fibrillar insoluble form of the beta-amyloid peptide (Abeta), are found in the hippocampus and neocortex of Alzheimer's disease (AD) patients...
2.
Matsell D, Roy 3rd S, Tamerius J, Morrow P, KOLB W, Wyatt R
Am J Kidney Dis
. 1991 Mar;
17(3):311-6.
PMID: 1996575
In most instances of acute poststreptococcal glomerulonephritis (APSGN), activation of the complement system occurs, as reflected by decreased levels of the complement proteins C3, C5, and properdin (P). Recent studies...
3.
ROSENBERG E, Noah P, Wyatt R, Jones R, KOLB W
Clin Exp Dermatol
. 1990 Jan;
15(1):16-20.
PMID: 2311273
Plasma from 16 patients with psoriasis and 12 healthy control subjects were measured for iC3b, C4d, and Bb fragments generated by complement activation. Plasma concentrations for iC3b, C4d, and Bb...
4.
Reed W, Roubey R, Dalzell J, Matteucci B, Myones B, Hunt 3rd S, et al.
Immunogenetics
. 1990 Jan;
31(3):145-51.
PMID: 1969382
Human B and T lymphoblastoid cell lines were shown to synthesize C5. C5 synthesis was quantitated with an enzyme-linked immunosorbent assay (ELISA) that utilized a pool of C5-specific monoclonal antibodies...
5.
KOLB W, Morrow P, Tamerius J
Complement Inflamm
. 1989 Jan;
6(3):175-204.
PMID: 2472921
Factor B is a centrally important component of the alternative complement pathway. Alternative pathway activation results in factor B cleavage and production of the amino-terminal Ba and the carboxyl-terminal Bb...
6.
Crawford M, Grover F, KOLB W, McMahan C, ORourke R, McManus L, et al.
Circulation
. 1988 Dec;
78(6):1449-58.
PMID: 3191598
Complement depletion with cobra venom factor (CVF) before coronary artery ligation has been previously shown to reduce subsequent ischemic myocardial tissue injury in the baboon; however, whether complement depletion after...
7.
Jones M, KOLB W, HARPER M
Immunol Invest
. 1988 Mar;
17(1):63-75.
PMID: 3391652
The fifth component of complement (C5) has been detected in rabbit uterine flushings. The C5 activity was evaluated using a hemolytic assay which requires the use of a C5-depleted reagent...
8.
Stewart J, KOLB W, Sodetz J
J Immunol
. 1987 Sep;
139(6):1960-4.
PMID: 3624872
The aim of this study was to identify constituents of the intermediate C5b-7 complex of human complement that mediate binding of C8 and formation of C5b-8. Analysis of interactions between...
9.
Fowler S, Seidenfeld J, Collins J, KOLB W
Am Rev Respir Dis
. 1987 Sep;
136(3):691-7.
PMID: 3631740
A series of studies was performed in which Syrian golden hamsters were injected intratracheally with 25 to 200 micrograms of highly purified human C5 or the 200,000 molecular weight form...
10.
KOLB W, Savary J, Troup C, Dodd D, Tamerius J
Environ Health Perspect
. 1987 Jun;
72:189-95.
PMID: 3622434
The ability of MIC to induce complement activation in vitro and in vivo was investigated. For the in vitro studies, both human and guinea pig serum or EDTA-plasma samples were...